Gabapentin provides no added benefit to multimodal analgesia for total knee arthroplasty
Gabapentin does not improve multimodal analgesia outcomes for total knee arthroplasty: a randomized controlled trialCan J Anaesth. 2013 May;60(5):423-31. doi: 10.1007/s12630-013-9902-1. Epub 2013 Mar 12.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Dr. J. E. Paul discusses how Gabapentin provides no added benefit to multimodal analgesia for total knee arthroplasty
101 total knee arthroplasty patients were randomized to evaluate gabapentin’s efficacy in reducing pain and morphine consumption. They were allocated to receive gabapentin 600 mg preoperatively followed by 200 mg every eight hours for two days or to the same regimen of placebo treatment. Evaluation after the 72-hour study period demonstrated no differences between the two treatment groups in posto...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE